Zhangzhou Pientzehuang Pharmaceutical Co.,Ltd. provided earnings guidance for the first quarter of 2017. The company's expected net profit to rise 50% to 60% from a year earlier in the first quarter of 2017, due to increasing sales volume and control over costs and expenditure.